Dow Up 0.35% Nasdaq Down 0.02%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
1.56 Down 0.08(4.88%) Aug 20, 4:00PM EDT
Prev Close:1.64
Open:1.64
Bid:1.51 x 8500
Ask:2.06 x 1000
1y Target Est:5.63
Beta:2.28
Next Earnings Date:N/A
Day's Range:1.51 - 1.64
52wk Range:1.46 - 3.93
Volume:407,036
Avg Vol (3m):381,058
Market Cap:124.08M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTX

Comparison

Symbol% ChgMkt Cap
CYTXDown 4.88%124.08M
ASTMDown 1.07%24.10M
BAXUp 0.16%40.76B
OSIRDown 0.76%490.62M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Sep-14) :-0.10
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback